Qube Research & Technologies (QRT)’s LENZ Therapeutics LENZ Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.74M	Buy	+482,195	New	+$3.89M	﹤0.01%	1978
2026 Q1	–	Sell	-44,290	Closed	-$709K	–	4237
2025 Q4	$709K	Buy	+44,290	New	+$1.29M	﹤0.01%	2695
2024 Q2	–	Sell	-982	Closed	-$21.9K	–	4872
2024 Q1	$21.9K	Buy	+982	New	+$20.4K	﹤0.01%	3676
2023 Q1	–	Sell	-3,872	Closed	-$90K	–	3116
2022 Q4	$90K	Buy	3,872 +1,016	+36%	+$23.6K	﹤0.01%	2029
2022 Q3	$63K	Buy	2,856 +336	+13%	+$8.01K	﹤0.01%	2090
2022 Q2	$49K	Buy	+2,520	New	+$56.2K	﹤0.01%	2133
2021 Q3	–	Sell	-2,100	Closed	-$452K	–	2869
2021 Q2	$452K	Buy	+2,100	New	+$366K	0.01%	1337

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LENZ Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 482,195 shares worth $2.74M. The stake represents ﹤0.01% of the portfolio and ranks #1978 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in LENZ as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in LENZ in Q2 2021 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Qube Research & Technologies (QRT) held 482,195 shares of LENZ Therapeutics worth $2.74M as of Q2 2026.
LENZ Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
LENZ Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1978 holding.
Qube Research & Technologies (QRT) first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 7 quarters since.
144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.